Adicet Bio, Inc.
ACETNasdaqCIK 1720580HealthcareFiscal year ends Dec 26
Reports and events: 220 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2808:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001720580-26-000060 |
| 2026-09-0816:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001720580-26-000056 |
| 2026-09-0107:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001720580-26-000054 |
| 2026-08-0516:21 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001720580-26-000050 |
| 2026-08-0516:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001720580-26-000049 |
| 2026-06-1816:01 ET | 8-K | 5.07 Shareholder vote results | 0001720580-26-000043 |
| 2026-05-2016:10 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001720580-26-000042 |
| 2026-05-1316:32 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001720580-26-000037 |
| 2026-05-1316:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001720580-26-000036 |
| 2026-04-2916:02 ET | DEF 14A | Proxy statementPeriod 2026-04-29 | 0001720580-26-000027 |
| 2026-04-2816:01 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001720580-26-000023 |
| 2026-04-1020:27 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-26-000427 |
| 2026-03-1216:27 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001720580-26-000008 |
| 2026-03-1216:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001720580-26-000006 |
| 2026-01-0708:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-005486 |
| 2025-12-2908:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-332343 |
| 2025-12-1916:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-326784 |
| 2025-11-1716:01 ET | DEF 14A | Proxy statementPeriod 2025-12-19 | 0001193125-25-284586 |
| 2025-11-0516:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-266880 |
| 2025-11-0516:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266860 |
| 2025-10-1019:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-25-000897 |
| 2025-10-0716:01 ET | 8-K | 3.01 Delisting notice | 0001193125-25-233427 |
| 2025-10-0707:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-232558 |
| 2025-10-0706:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-232539 |
| 2025-08-0716:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104978 |
| 2025-08-0716:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104969 |
| 2025-07-2316:01 ET | 8-K | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-097881 |
| 2025-06-1316:02 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-086120 |
| 2025-05-0616:07 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-064448 |
| 2025-05-0616:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-064423 |
| 2025-04-2916:07 ET | DEF 14A | Proxy statementPeriod 2025-04-29 | 0000950170-25-060104 |
| 2025-04-1707:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-054995 |
| 2025-04-1116:01 ET | 8-K | 3.01 Delisting notice | 0000950170-25-053238 |
| 2025-03-0616:04 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-034587 |
| 2025-03-0616:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-034580 |
| 2025-02-0507:01 ET | 8-K | 8.01 Other events | 0000950170-25-014153 |
| 2024-12-1916:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-138419 |
| 2024-11-2717:12 ET | 8-K | 1.02 Termination of a material agreement | 0000950170-24-131609 |
| 2024-11-1816:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-127927 |
| 2024-11-1516:03 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-127560 |
| 2024-11-0616:03 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122253 |
| 2024-11-0616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122244 |
| 2024-10-1607:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-114839 |
| 2024-09-3007:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-110166 |
| 2024-09-1907:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-107988 |
| 2024-09-1007:01 ET | 8-K | 8.01 Other events | 0000950170-24-104915 |
| 2024-08-1916:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-098485 |
| 2024-08-1307:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095745 |
| 2024-08-1307:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095744 |
| 2024-07-0807:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-081943 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.